CSPC Pharmaceutical Group Limited (FRA:CVG)

Germany flag Germany · Delayed Price · Currency is EUR
0.7276
+0.0076 (1.06%)
At close: May 21, 2025, 10:00 PM CET
-8.48%
Market Cap 11.33B
Revenue (ttm) 3.45B
Net Income (ttm) 534.62M
Shares Out n/a
EPS (ttm) 0.05
PE Ratio 21.19
Forward PE 17.87
Dividend 0.03 (4.15%)
Ex-Dividend Date Jun 4, 2025
Volume 1,000
Average Volume 4,497
Open 0.7258
Previous Close 0.7200
Day's Range 0.7258 - 0.7276
52-Week Range 0.5108 - 0.9490
Beta n/a
RSI 76.07
Earnings Date May 23, 2025

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment; Enxi to treat adult idiopathic Parkinson’s disease; Duomeisu for lymphoma,... [Read more]

Industry Pharmaceutical Preparations
Founded 1992
Employees 21,400
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol CVG
Full Company Profile

Financial Performance

In 2024, CSPC Pharmaceutical Group's revenue was 29.01 billion, a decrease of -7.76% compared to the previous year's 31.45 billion. Earnings were 4.33 billion, a decrease of -26.31%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.